Should You Sell Replimune Group Inc (REPL) in Biotechnology Industry?

Replimune Group Inc (REPL) is near the top in its industry group according to InvestorsObserver. REPL gets an overall rating of 67. That means it scores higher than 67 percent of stocks. Replimune Group Inc gets a 89 rank in the Biotechnology industry. Biotechnology is number 67 out of 148 industries.

REPL has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on REPL!

See Full REPL Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 67 means the stock is more attractive than 67 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Replimune Group Inc Stock Today?

Replimune Group Inc (REPL) stock is trading at $20.72 as of 1:00 PM on Monday, Aug 28, an increase of $0.17, or 0.83% from the previous closing price of $20.55. The stock has traded between $20.56 and $20.86 so far today. Volume today is light. So far 57,965 shares have traded compared to average volume of 496,118 shares. Click Here to get the full Stock Report for Replimune Group Inc stock.